Cargando…
Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma
To successfully target Notch receptors as part of a multidrug anticancer strategy, it will be essential to fully characterize the factors that are modulated by Notch signaling. We recently reported that Notch3 silencing in HCC results in p53 up-regulation in vitro and, therefore, we focused on the m...
Autores principales: | Giovannini, Catia, Minguzzi, Manuela, Baglioni, Michele, Fornari, Francesca, Giannone, Ferdinando, Ravaioli, Matteo, Cescon, Matteo, Chieco, Pasquale, Bolondi, Luigi, Gramantieri, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279397/ https://www.ncbi.nlm.nih.gov/pubmed/25431954 |
Ejemplares similares
-
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2016) -
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2017) -
Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2017) -
Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3β phosphorylation and p21 down-regulation in hepatocellular carcinoma
por: Giovannini, Catia, et al.
Publicado: (2013) -
LncRNAs as novel players in hepatocellular carcinoma recurrence
por: Gramantieri, Laura, et al.
Publicado: (2018)